Intrasense (ALINS) - Total Liabilities

Latest as of December 2025: €14.45 Million EUR ≈ $16.89 Million USD

Based on the latest financial reports, Intrasense (ALINS) has total liabilities worth €14.45 Million EUR (≈ $16.89 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Intrasense - Total Liabilities Trend (2008–2025)

This chart illustrates how Intrasense's total liabilities have evolved over time, based on quarterly financial data. See ALINS current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Intrasense Competitors by Total Liabilities

The table below lists competitors of Intrasense ranked by their total liabilities.

Company Country Total Liabilities
Acrinova AB
ST:ACRI-A
Sweden Skr453.97 Million
Investsmart Group Ltd
AU:INV
Australia AU$6.41 Million
Copaur Minerals Inc
V:CPAU
Canada CA$182.98K
Andalan Sakti Primaindo PT
JK:ASPI
Indonesia Rp30.76 Billion
Celsius Resources Limited
F:FX8
Germany €1.07 Million
Asuransi Jasa Tania Tbk
JK:ASJT
Indonesia Rp255.97 Billion
Park Ha Biological Technology Co., Ltd.
NASDAQ:PHH
USA $1.58 Million
Way 2 Vat Ltd
AU:W2V
Australia AU$7.17 Million

Liability Composition Analysis (2008–2025)

This chart breaks down Intrasense's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ALINS stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.26 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -2.24 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.81 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Intrasense's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Intrasense (2008–2025)

The table below shows the annual total liabilities of Intrasense from 2008 to 2025.

Year Total Liabilities Change
2025-12-31 €14.45 Million
≈ $16.89 Million
+139.65%
2024-12-31 €6.03 Million
≈ $7.05 Million
+90.52%
2023-12-31 €3.17 Million
≈ $3.70 Million
-29.62%
2022-12-31 €4.50 Million
≈ $5.26 Million
+18.87%
2021-12-31 €3.78 Million
≈ $4.42 Million
-10.10%
2020-12-31 €4.21 Million
≈ $4.92 Million
+15.83%
2019-12-31 €3.63 Million
≈ $4.25 Million
+62.78%
2018-12-31 €2.23 Million
≈ $2.61 Million
-3.94%
2017-12-31 €2.32 Million
≈ $2.72 Million
-23.55%
2016-12-31 €3.04 Million
≈ $3.55 Million
-22.58%
2015-12-31 €3.93 Million
≈ $4.59 Million
+5.42%
2014-12-31 €3.72 Million
≈ $4.35 Million
-9.28%
2013-12-31 €4.11 Million
≈ $4.80 Million
+1.47%
2012-12-31 €4.05 Million
≈ $4.73 Million
-33.73%
2011-12-31 €6.11 Million
≈ $7.14 Million
+85.71%
2010-12-31 €3.29 Million
≈ $3.84 Million
+210.42%
2009-12-31 €1.06 Million
≈ $1.24 Million
+22.00%
2008-12-31 €868.00K
≈ $1.01 Million
--

About Intrasense

PA:ALINS France Health Information Services
Market Cap
$14.78 Million
€12.64 Million EUR
Market Cap Rank
#26382 Global
#444 in France
Share Price
€0.24
Change (1 day)
+1.69%
52-Week Range
€0.19 - €0.31
All Time High
€2.17
About

Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, an oncological imaging platform that… Read more